Literature DB >> 3312588

Phosphoethanolamine transiently enhances excitability of rat hippocampal neurons in vitro.

M Zeise1, A Lehmann.   

Abstract

Application of phosphoethanolamine (PEA; more than 1 mM) to rat hippocampal neurons leads to a change in excitability in two phases: a) A transient increase of EPSP amplitude and membrane input resistance (Ri) in the order of minutes that can be observed after local as well as bath application. b) Decrease of EPSP and IPSP amplitude and of Ri are caused by exposure to PEA (over 1 mM; bath application) for more than 20 min. Membrane potential and action potential are not changed by 10 mM PEA for up to half an hour. Depolarizations evoked by N-methyl-D,L-aspartate (NMA) given locally are transiently enhanced and then reduced by PEA following a time course similar to the effects a) and b) observed on EPSPs. PEA produces an apparent decrease of calcium activity due to its electrochemical properties. A local application into the soma layer results in a complex calcium signal. A shortlasting drop in calcium activity is followed by a large positive signal indicating an increase of calcium activity. It is concluded that liberation of PEA exacerbates rather than mitigates the harmful consequences of strong excitation and/or excitotoxins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312588     DOI: 10.1007/BF00603971

Source DB:  PubMed          Journal:  J Comp Physiol A            Impact factor:   1.836


  14 in total

1.  The excitation and depression of spinal neurones by structurally related amino acids.

Authors:  D R CURTIS; J C WATKINS
Journal:  J Neurochem       Date:  1960-09       Impact factor: 5.372

2.  Taurine on hippocampal slices: comparison to GABA and glycine, and antagonism by 4-aminopyridine.

Authors:  M Zeise
Journal:  Prog Clin Biol Res       Date:  1985

3.  Regional alterations of synaptic O-phosphorylethanolamine in differentially housed mice.

Authors:  W B Essman
Journal:  Pharmacol Res Commun       Date:  1974-08

4.  Effects of status epilepticus on extracellular amino acids in the hippocampus.

Authors:  A Lehmann; H Hagberg; I Jacobson; A Hamberger
Journal:  Brain Res       Date:  1985-12-16       Impact factor: 3.252

5.  N-Methylaspartate-evoked liberation of taurine and phosphoethanolamine in vivo: site of release.

Authors:  A Lehmann; J W Lazarewicz; M Zeise
Journal:  J Neurochem       Date:  1985-10       Impact factor: 5.372

6.  Action of excitatory amino acids and their antagonists on hippocampal neurons.

Authors:  J J Hablitz
Journal:  Cell Mol Neurobiol       Date:  1985-12       Impact factor: 5.046

7.  Excitatory amino acids and epilepsy-induced changes in extracellular space size.

Authors:  U Heinemann
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

8.  N-methyl aspartate activates voltage-dependent calcium conductance in rat hippocampal pyramidal cells.

Authors:  R Dingledine
Journal:  J Physiol       Date:  1983-10       Impact factor: 5.182

9.  In vivo brain dialysis of amino acids and simultaneous EEG measurements following intrahippocampal quinolinic acid injection: evidence for a dissociation between neurochemical changes and seizures.

Authors:  A Vezzani; U Ungerstedt; E D French; R Schwarcz
Journal:  J Neurochem       Date:  1985-08       Impact factor: 5.372

10.  Subcellular distribution of neuroactive amino acids in brains of genetically epileptic rats.

Authors:  D W Bonhaus; S E Lippincott; R J Huxtable
Journal:  Epilepsia       Date:  1984-10       Impact factor: 5.864

View more
  2 in total

1.  Co-variation of free amino acids in human epileptogenic cortex.

Authors:  A Hamberger; K Haglid; B Nyström; H Silfvenius
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

Review 2.  Classical and Unexpected Effects of Ultra-Micronized PEA in Neuromuscular Function.

Authors:  Pierangelo Cifelli; Gabriele Ruffolo; Marco Ceccanti; Chiara Cambieri; Laura Libonati; Eleonora Palma; Maurizio Inghilleri
Journal:  Biomolecules       Date:  2022-05-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.